Healthcare provider profile · identity verified

Kevin Benjamine Mcbride, M.D.

Family Practice · STARKE, FL · NPI 1790791721

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	418	138
Amlodipine Besylate	Amlodipine Besylate	393	130
Lisinopril	Lisinopril	247	82
Levothyroxine Sodium	Levothyroxine Sodium	232	75
Metformin Hcl	Metformin Hcl	206	70
Omeprazole	Omeprazole	206	67
Fluticasone Propionate	Fluticasone Propionate	189	71
Gabapentin	Gabapentin	173	58
Losartan Potassium	Losartan Potassium	170	59
Albuterol Sulfate Hfa	Albuterol Sulfate	165	52
Rosuvastatin Calcium	Rosuvastatin Calcium	161	58
Tamsulosin Hcl	Tamsulosin Hcl	147	42
Furosemide	Furosemide	141	37
Carvedilol	Carvedilol	137	44
Pantoprazole Sodium	Pantoprazole Sodium	133	40
Metoprolol Succinate	Metoprolol Succinate	118	38
Montelukast Sodium	Montelukast Sodium	118	37
Eliquis	Apixaban	98	21
Simvastatin	Simvastatin	98	31
Potassium Chloride	Potassium Chloride	95	34
Alprazolam	Alprazolam	81	22
Hydrochlorothiazide	Hydrochlorothiazide	78	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	27
Tramadol Hcl	Tramadol Hcl	65	30
Allopurinol	Allopurinol	64	20
Tizanidine Hcl	Tizanidine Hcl	64	14
Lorazepam	Lorazepam	61	18
Metformin Hcl Er	Metformin Hcl	61	17
Duloxetine Hcl	Duloxetine Hcl	60	18
Trazodone Hcl	Trazodone Hcl	59	26
Ibuprofen	Ibuprofen	57	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	18
Symbicort	Budesonide/Formoterol Fumarate	54	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	53	16
Meloxicam	Meloxicam	51	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	46	22
Sertraline Hcl	Sertraline Hcl	45	14
Jardiance	Empagliflozin	44	17
Pioglitazone Hcl	Pioglitazone Hcl	43	14
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Baclofen	Baclofen	41	suppressed
Pravastatin Sodium	Pravastatin Sodium	39	16
Escitalopram Oxalate	Escitalopram Oxalate	38	14
Bupropion Xl	Bupropion Hcl	37	11
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Lovastatin	Lovastatin	36	12
Alendronate Sodium	Alendronate Sodium	35	suppressed
Atenolol	Atenolol	35	11
Buspirone Hcl	Buspirone Hcl	35	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	14
Januvia	Sitagliptin Phosphate	35	suppressed
Ozempic	Semaglutide	35	11
Famotidine	Famotidine	34	suppressed
Spironolactone	Spironolactone	34	13
Triamcinolone Acetonide	Triamcinolone Acetonide	34	14
Doxazosin Mesylate	Doxazosin Mesylate	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	14
Glipizide	Glipizide	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	14
Ropinirole Hcl	Ropinirole Hcl	32	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Finasteride	Finasteride	30	suppressed
Xarelto	Rivaroxaban	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	11
Prednisone	Prednisone	28	12
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Pregabalin	Pregabalin	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Azithromycin	Azithromycin	23	17
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Nitroglycerin	Nitroglycerin	23	11
Spiriva Handihaler	Tiotropium Bromide	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Valsartan	Valsartan	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Methylprednisolone	Methylprednisolone	19	18
Nystatin	Nystatin	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Topiramate	Topiramate	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Emgality Pen	Galcanezumab-Gnlm	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nateglinide	Nateglinide	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error